DO HIGH RHEUMATOID FACTOR LEVELS IMPACT RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH INADEQUATELY CONTROLLED RHEUMATOID ARTHRITIS? A POST HOC ANALYSIS OF THE PHASE 3B REALISTIC TRIAL

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2024
This article has no abstract
Epistemonikos ID: 1fdef14e1a7723535b1e3cb70d8dcf3f77365eff
First added on: Feb 18, 2025